
|Articles|July 8, 2008
FDA approves Evolence for treating facial wrinkles
National report - The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson.
Advertisement
National report
- The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson.
Evolence is made from collagen harvested from the tendons of pigs, and will compete on the market with synthetic dermal fillers, such as Restylane (Medicis) and Juvéderm (Allergan), the Washington Post reports.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
World Cancer Day 2026: La Roche-Posay and ONS Partner to Launch Skin of Color Toxicity Repository
4
Journal Digest: February 4, 2026
5











